Volume 33, Issue 2 (May 2022)
Studies in Medical Sciences 2022, 33(2): 100-105 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Bahadori F, Behdad M, Vahabi A. EVALUATION OF THE RELATIONSHIP BETWEEN SECOND TRIMESTER SCREENING TESTS, ULTRASOUND AND AMNIOCENTESIS FINDINGS IN THE DIAGNOSIS OF SMITH-LEMLI-OPTIZ SYNDROME IN HIGH-RISK CASES. Studies in Medical Sciences 2022; 33 (2) :100-105
URL: http://umj.umsu.ac.ir/article-1-5788-en.html
URL: http://umj.umsu.ac.ir/article-1-5788-en.html
Department of Medical Genetics and Immunology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran (Corresponding author) , ali.vahabi@hotmail.com
Abstract: (2168 Views)
Background & Aims: Smith-Lemli-Opitz syndrome (SLOs) is a developmental disorder with an autosomal recessive pattern of inheritance. During pregnancy, if screening tests in the second trimester of pregnancy show an increased risk of SLOs, additional complementary studies including ultrasound and genetic testing on amniotic fluid are performed. This study aimed to investigate the relationship between second trimester screening tests, ultrasound, and amniocentesis findings in SLOs occurrence.
Materials & Methods: This study was a cross-sectional descriptive study. 44 pregnant women referred to the perinatology department of Shahid Motahari Medical Education Center with positive results for SLOs were included in the study. The correlation between second trimester screening tests, ultrasound and amniocentesis findings in confirming SLOs as well as DHCR7 gene expression in terms of common IVS8-1G>C mutation were measured.
Results: Data showed that one of 44 cases with high-risk second trimester screening test for SLOs was positive for IVS8-1G>C mutation of DHCR7 gene.
Conclusion: The findings showed that although positive screening tests are new screening methods for SLOs, genetic tests are also needed for definitive diagnosis.
Materials & Methods: This study was a cross-sectional descriptive study. 44 pregnant women referred to the perinatology department of Shahid Motahari Medical Education Center with positive results for SLOs were included in the study. The correlation between second trimester screening tests, ultrasound and amniocentesis findings in confirming SLOs as well as DHCR7 gene expression in terms of common IVS8-1G>C mutation were measured.
Results: Data showed that one of 44 cases with high-risk second trimester screening test for SLOs was positive for IVS8-1G>C mutation of DHCR7 gene.
Conclusion: The findings showed that although positive screening tests are new screening methods for SLOs, genetic tests are also needed for definitive diagnosis.
References
1. Witters I, Moerman P, Cannie M, Catte LD, Fryns J-P. Prenatal Diagnosis of Smith-Lemli-Opitz Syndrome. Ultrasound 2008;16(4):208-10. [DOI:10.1179/174313408X353855]
2. Porter FD. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. Eu J Hum Genet 20;16 (5):535 -41. [DOI:10.1038/ejhg.2008.10] [PMID]
3. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. New Eng J Med 1994;330(2):107-13. [DOI:10.1056/NEJM199401133300205] [PMID]
4. Dugoff L. First-and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes. Obstetr Gynecol 2010;115(5):1052-61. [DOI:10.1097/AOG.0b013e3181da93da] [PMID]
5. Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J. Williams obstetrics, 24e: Mcgraw-hill; 2014. [URL]
6. Shinawi M, Szabo S, Popek E, Wassif CA, Porter FD, Potocki L. Recognition of Smith-Lemli-Opitz syndrome (RSH) in the fetus: Utility of ultrasonography and biochemical analysis in pregnancies with low maternal serum estriol. Am J Med Genet 2005;138(1):56-60. [DOI:10.1002/ajmg.a.30898] [PMID]
7. Linck L, Hayflick S, Lin D, Battaile K, Ginat S, Burlingame T, et al. Fetal demise with Smith-Lemli-Opitz syndrome confirmed by tissue sterol analysis and the absence of measurable 7‐dehydrocholesterol Δ7‐reductase activity in chorionic villi. Prenatal Diagnosis. Int Soc Prenat Diag 2000;20(3):238-40.
https://doi.org/10.1002/(SICI)1097-0223(200003)20:3<238::AID-PD792>3.0.CO;2-W [DOI:10.1002/(SICI)1097-0223(200003)20:33.0.CO;2-W]
8. Jira P, Wanders R, Smeitink J, De Jong J, Wevers R, Oostheim W, et al. Novel mutations in the 7-dehydrocholesterol reductase gene of 13 patients with Smith-Lemli-Opitz syndrome. Ann Hum Genet 2001;65(3):229-36. [DOI:10.1046/j.1469-1809.2001.6530229.x] [PMID]
9. Kratz LE, Kelley RI. Prenatal diagnosis of the RSH/Smith‐Lemli‐Opitz syndrome. Am J Med Genet 1999;82(5):376-81.
https://doi.org/10.1002/(SICI)1096-8628(19990219)82:5<376::AID-AJMG4>3.0.CO;2-B [DOI:10.1002/(SICI)1096-8628(19990219)82:53.0.CO;2-B]
10. Bick D, McCorkle D, Stanley W, Stern H, Staszak P, Berkovitz G, et al. Prenatal diagnosis of Smith-Lemli-Opitz syndrome in a pregnancy with low maternal serum oestriol and a sex‐reversed fetus. Prenatal Diagnosis. Int Soc Prenat Diag 1999;19(1):68-71.
https://doi.org/10.1002/(SICI)1097-0223(199901)19:1<68::AID-PD461>3.0.CO;2-3 [DOI:10.1002/(SICI)1097-0223(199901)19:13.0.CO;2-3]
11. Schoen E, Norem C, O'Keefe J, Krieger R, Walton D, To TT. Maternal serum unconjugated estriol as a predictor for Smith-Lemli-Opitz syndrome and other fetal conditions. Obstetr Gynecol 2003;102(1):167-72.
https://doi.org/10.1097/00006250-200307000-00031 [DOI:10.1016/S0029-7844(03)00370-3]
12. Battaile KP, Battaile BC, Merkens LS, Maslen CL, Steiner RD. Carrier frequency of the common mutation IVS8-1G> C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome. Mol Genet Metab 2001;72(1):67-71. [] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
